Center for Research on Inflammation of the Skin (CRIS)

The Center for Research on Inflammation of the Skin (CRIS) is a multidisciplinary research center focused on inflammatory skin diseases. The members of CRIS participate in 5 DFG-funded research consortia, including the Clinical Research Units (CRU) 303 and 170, the Research Training Group (RTG) 1727 and 1743 as well as the Excellence Cluster (EXC) 306 Inflammation-at-Interfaces.
CRIS was established as successor organization of the the Autoimmune Blistering Diseases Research (CAIBR), which was solely dedicated to research on autoimmune blistering skin diseases.

Clinical Research Units 303

Clinical Research Units 170

Research Training Group 1727

Research Training Group 1743

Excellence Cluster 306

The members of the CRIS recruit from the Department of Dermatology, the Department of Rheumatology, the Institute for Systemic Inflammation Research (ISEF), the Lübeck Institute of Experimental Dermatology (LIED), the Institute of Medical Biomedtry and Statistics, and the Comprehensive Center for Inflammation Medicine (CCIM).

Department of Dermatology

Institute for Systemic Inflammation Research

Lübeck Institute for Experimental Dermatology (LIED) 

Institute of Medical Biometry and Statistics

Comprehensive Center for Inflammation Medicine (CCIM) 

Department of Rheumatology

As an institution of the University of Lübeck, CRIS closely interacts with the University Clinic of Schleswig-Holstein (UKSH) merging preclinical research with clinical research, and patient care.

CRIS aims at developing new drugs for inflammatory skin diseases and to advance treatment of these diseases to the precision medicine level. The research of the CRIS is currently focused on pemphigoid diseases, ANCA-positive vasculitis, and scleroderma.